Zhang Wei, Fang Yu, Shi Minfeng, Zhang Mingzhen, Chen Yuangui, Zhou Tie
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Reproductive Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Transl Androl Urol. 2021 Jan;10(1):143-153. doi: 10.21037/tau-20-913.
The study aims to perform a meta-analysis of published trials and evaluate the efficacy of acupuncture on chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) by symptom score reduction, optimal acupuncture session, and most frequently used acupoints.
A literature search was performed for randomized controlled trials (RCTs) comparing efficacy of acupuncture with sham acupuncture or standard medication on CP/CPPS. The primary outcome was the reduction of National Institute of Health-Chronic Prostatitis Index (NIH-CPSI) total score and its subscales. The optimal acupuncture session to reach its clinical efficacy and most common compatibility rule of acupoints were also evaluated.
Ten trials involving 770 participants were included. Meta-analysis showed compared with sham acupuncture, acupuncture yielded significant reduction in NIH-CPSI total score [weighted mean difference (WMD): 7.28, 95% confidence interval (95% CI): 5.69-8.86), and provided better pain relief (WMD: 3.57, 95% CI: 2.07-5.08), urinary symptoms improvement (WMD: 1.68, 95% CI: 1.13-2.22), and quality of life (QOL) (WMD: 2.38, 95% CI: 1.41-3.36). Compared with standard medication, acupuncture were more efficacious in reducing NIH-CPSI total score (WMD: 3.36, 95% CI: 1.27-5.45), also showed significant greater pain relief (WMD: 2.36, 95% CI: 1.67-3.06), marginal advantage in improving QOL (WMD: 0.98, 95% CI: 0.12-1.83) but no difference in reducing urinary symptom (WMD: -0.03, 95% CI: -1.30 to 1.24). Four acupuncture sessions were the minimum "dose" to reach clinical efficacy, and prolonged acupuncture sessions continuously improved urinary symptoms and QOL. The majority of acupoint selection strategies were based on the combination of any three acupoints from CV3, CV4, BL32, SP6, and SP9.
Acupuncture has promising efficacy for patients with CP/CPPS, especially category IIIB, in aspects of relieving pain and urinary symptoms and improving the QOL. Acupuncture may serve as a standard treatment option when available, and a tailored comprehensive treatment strategy for CP/CPPS is the future trend.
本研究旨在对已发表的试验进行荟萃分析,并通过症状评分降低、最佳针刺疗程和最常用穴位来评估针刺治疗慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)的疗效。
检索比较针刺与假针刺或标准药物治疗CP/CPPS疗效的随机对照试验(RCT)。主要结局是美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)总分及其子量表的降低。还评估了达到临床疗效的最佳针刺疗程以及最常见的穴位配伍规律。
纳入10项试验,共770名参与者。荟萃分析显示,与假针刺相比,针刺使NIH-CPSI总分显著降低[加权均数差(WMD):7.28,95%置信区间(95%CI):5.69-8.86],并能更好地缓解疼痛(WMD:3.57,95%CI:2.07-5.08)、改善排尿症状(WMD:1.68,95%CI:1.13-2.22)和提高生活质量(QOL)(WMD:2.38,95%CI:1.41-3.36)。与标准药物相比,针刺在降低NIH-CPSI总分方面更有效(WMD:3.36,95%CI:1.27-5.45),在缓解疼痛方面也更显著(WMD:2.36,95%CI:1.67-3.06),在改善生活质量方面有一定优势(WMD:0.98,95%CI:0.12-1.83),但在减轻排尿症状方面无差异(WMD:-0.03,95%CI:-1.30至1.24)。四个针刺疗程是达到临床疗效的最小“剂量”,延长针刺疗程可持续改善排尿症状和生活质量。大多数穴位选择策略基于任取中极(CV3)、关元(CV4)、膀胱俞(BL32)、三阴交(SP6)和阴陵泉(SP9)中的三个穴位进行配伍。
针刺对CP/CPPS患者,尤其是IIIB型患者,在缓解疼痛、排尿症状和提高生活质量方面具有显著疗效。针刺在可行时可作为标准治疗选择,为CP/CPPS制定个性化的综合治疗策略是未来的发展趋势。